Study Title: Social Inclusion and People Living with Schizophrenia

Study Title: Social Inclusion and People Living with Schizophrenia

More details about this 2013 study

This survey is for THE CARERS of people living with schizophrenia.

The study is part of a range of activities that the Swiss pharmaceutical company, F. Hoffmann-La Roche, is undertaking with patient organisations. The study DOES NOT look at treatment or the effects of treatment for schizophrenia, but instead aims to identify some of the challenges faced by people who are affected by schizophrenia—particularly the challenge of being ‘socially included’ in society. The intention is to find out how healthcare policy can improve, and present this information to policymakers.

The study is using a new definition of the term SOCIALLY INCLUDED (see foot of this email).

Who is managing this survey?

PatientView is managing this survey on behalf of Roche. PatientView is a UK research organisation that works closely with patient groups, and publicises the patient movement.

Anonymity

Everyone who takes part in this survey will be completely ANONYMOUS, and no IP addresses will be collected by the survey managers.

However, anyone who takes part and wishes to OBTAIN THE RESULTS OF THE SURVEY can leave an email address at the end of the survey questionnaire.

The survey will close on Monday August 19th 2013.

Link to online questionnaire

[http://svy.mk/15cJXyd]

Thank you for your interest. If you have any further questions about this survey, please contact …

Dr Alexandra Wyke

CEO, PatientView

Tel: +44-(0)1547-520-965

E-mail: info@patient-view.com